Chapter 17: Skin Lesions

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

You know, you might look at the human body and think, uh, think of the skin as just wrapping paper.

Right.

Like a static boundary.

Exactly.

Just this layer designed to keep the outside out and the inside in.

You see a red bump and, um, you just assume it's a surface problem.

You prescribe a topical cream and move on.

Yeah.

But step into the clinic as an advanced practice nursing student and that illusion shatters immediately.

It really does because the skin is, uh, it's constantly flashing these really complex overlapping warning signs.

Welcome to this deep dive.

Today we are taking you on a masterclass in clinical reasoning.

We're looking at chapter 17, skin lesions.

And that single red bump you mentioned,

it could be a simple blocked pore, sure.

But it could also be a vascular reflex or, you know, a sign of underlying endocrine dysfunction.

Or even the earliest whisper of a deadly malignancy.

So our mission today is to turn that murky diagnostic landscape into a clear, navigable roadmap.

Which means unpacking the path of physiology, the assessment strategies, and the evidence -based management for all these lesions, benign, pre -malignant, malignant.

This is your one -on -one tutoring session to help you read the skin like, well, like a seasoned detective reading a crime scene.

And understanding that foundational science is the only way to avoid just guessing.

The biology dictates your physical assessment findings.

Right.

And those findings drive safe, patient -centered management.

Exactly.

Once you understand the underlying why, the decisions like what to prescribe, when to refer, when to biopsy, they just become completely logical.

So let's start building that foundation with the absolute most common skin condition you're going to see in primary care.

Acne vulgaris.

Makes sense.

Master the mundane before we tackle the complex imitators.

Right.

So what is acne, fundamentally?

It's basically an inflammatory disorder of the polyspacious unit.

So picture the sebaceous gland and the hair follicle it surrounds.

Okay.

The path of physiology follows a super predictable cascade.

It usually kicks off in puberty when androgen hormone levels surge.

And those androgens hit the receptors on the sebaceous glands, right?

Yeah, sending them into complete overdrive.

They produce massive amounts of sebum.

Just oil everywhere.

But I mean, oil alone doesn't cause a pimple.

No, it doesn't.

There's a secondary failure happening at the cellular level.

It's called retention hyperkeratosis.

Retention hyperkeratosis.

So the cells aren't shedding properly.

Exactly.

Normally, the epithelial cells lining the follicle slew off and just float away.

But in acne -prone skin, that desquamation process slows down.

The shed cells become incredibly sticky.

I always think of it like a traffic jam inside the hair follicle, like those sticky unshed cells of the car accident completely blocking the road.

That's a great analysis.

And then all that excess sebum being pumped out is the backed up traffic that just can't get past the accident.

Right.

And trapped inside that blocked oxygen -deprived traffic jam is a bacterium, propionabacterium

Which is normally just hanging out on our skin, right?

Yeah, it's normal skin flora.

But in this specific blocked environment, it throws a feast.

It consumes the triglycerides in the sebum and breaks them down into free fatty acids.

And those fatty acids irritate the surrounding tissues.

So the P.

acnes bacteria are basically the angry drivers causing a riot in our traffic jam.

Pretty much.

They release chemotactic factors, these chemical distress signals that summon the immune system.

Neutrophils rush in and release an enzyme called lysozyme to kill the bacteria.

But lysozyme damages the follicle wall too, doesn't it?

It degrades it completely.

When the wall inevitably ruptures under all that pressure, the bacteria, sebum, and keratin violently spill into the dermis.

That tissue damage is what creates those deep, painful cysts.

Wow.

But before we get to that explosive rupture, the primary lesion is just the comdone.

Right.

And we need to distinguish between the two types.

Closed comdones are whiteheads.

The pore is covered by skin.

And open comdones are blackheads.

Which you know, I always assumed was trapped dirt.

Most patients do.

Oh, totally.

But that dark plug is actually caused by the oxidation of tyrosine.

It's an amino acid inside the keratin that turns dark when exposed to oxygen in the air.

That's fascinating.

So how do we assess and treat this clinically?

It depends on how far down that inflammatory cascade the patient has progressed.

Mild acne is primarily those non -inflammatory comdones.

Just the blackheads and whiteheads.

Moderate acne brings in the inflammatory papules and pustules.

And then severe acne, nodular cystic acne, involves those deep ruptures we talked about.

Which almost always lead to permanent scarring.

Unfortunately, yes.

Yep.

And as an APN, you have to recognize severe variants like acne conglobata, which produces interconnected cysts, mainly on the trunk.

Oh, wow.

Or acne fulminans, which is a rare acute eruption in young males that actually triggers systemic symptoms, like fever and joint pain.

We also have to think about the modern environment, like masking.

Definitely.

Masking is huge right now.

Triggered by the friction and trapped moisture of facial masks, especially if they aren't washed.

The pathophysiology is the same, but the intervention is really about preventative hygiene.

Washing the face twice daily, rotating clean masks, simple stuff, but highly effective.

Right.

So diagnostically, history and location are usually enough, but let me throw a clinical scenario at you.

Okay, let's hear it.

A 24 -year -old female patient sits in your exam room.

She has severe, stubborn acne localized entirely along her jawline, and she casually mentions her menstrual cycles are all over the place.

What's the clinical reasoning there?

Well, your reasoning has to shift from dermatology to endocrinology.

That presentation screams hyperandrogenism.

Specifically, it points toward polycystic ovary syndrome,

PCOS.

You can't just throw topical creams at a systemic hormone imbalance.

Exactly.

You need to order serum total and free testosterone levels.

And probably a pelvic ultrasound to look for ovarian cysts.

Let's assume it is just standard acne, though.

Evidence -based management.

First line from wild cases.

Topicals.

Benzoyl peroxide is fantastic because it pushes oxygen into the follicle, which kills the anaerobic P acnes.

There's also Clascoterone, right?

Brand name Winlevy.

Yeah.

It's an androgen receptor inhibitor.

It basically blocks the hormones from telling the sebaceous gland to pump out oil.

And for moderate to severe cases.

We escalate to systemic antibiotics,

oral minocycline or doxycycline, to shut down that massive bacterial inflammatory response.

But the real clinical challenge is that severe recalcitrant nodular acne that just ignores all of those treatments.

That is when we turn to oral isotretinone.

It's a vitamin A derivative, the nuclear option.

Because it hits all the causes.

All four of them.

It drastically shrinks the sebaceous glands, normalizes the epithelial shedding, destroys the P acnes environment, and halts the neutrophil -driven inflammation.

But this brings up a massive scope of practice and safety red flag for the APN student to know.

Isotretinone is a highly potent teratogen.

Catastrophic birth defects if taken during pregnancy.

The medical legal implications are immense.

So female patients of reproductive A should ideally be referred to DERM.

Yes.

And everyone involved, prescriber, pharmacy, patient, must be enrolled in the strict federally mandated IPLgist program.

Meaning two negative pregnancy tests before the first dose is even dispensed.

Plus a commitment to two distinct reliable forms of birth control.

One month before, continuously during, and for one full month after stopping the medication.

That is a safety protocol you absolutely must lock into your memory.

Absolutely.

Now, what happens when a patient walks in with a red bumpy face, but there isn't a single blocked pore in sight?

Then you are dealing with a vascular imposter.

Rosacea.

Right.

It's chronic, it's progressive, but it's vascular, not follicular.

Usually strikes middle -aged adults, predominantly those of Celtic descent, Irish, Scottish, or English ancestry.

And it's strictly on the central face, right?

The flush and blush areas, cheeks, nose, chin.

That's the classic presentation.

And there are four distinct subtypes to assess for.

Subtype one is erythematotelangiectatic.

That's a mouthful.

It is.

Basically persistent flushing and visible broken blood vessels.

Subtype two is capulopustular.

This is the acne imposter.

Transient red bumps and pus -filled lesions.

Okay, what about subtype three?

Femidus rosacea.

The sebaceous glands actually hypertrophy and the skin thickens.

This often causes rhinofemur.

Giving the nose that large, bulbous, distorted look.

Like W .C.

Fields.

Exactly like W .C.

Fields.

And finally, subtype four is ocular rosacea.

Causes dry, gritty, bloodshot eyes and recurrent styes.

Subtype two is where it gets tricky, though.

Let me play devil's advocate.

An adult presents with a fiery red face covered in papules.

How do I prove it's rosacea and not adult -onset acne?

Or you know, the butterfly rash of systemic lupus.

You run your differential diagnosis by looking for what is absent.

Rosacea produces papules and pustules, but it never produces comedones.

So no blackheads, no whiteheads.

Right.

If you see comedones, it's acne.

Also look at the exact geography of the rash.

Rosacea involves the central face, but spears a clear skin right around the lips.

If the perioral area is involved, you might be looking at perioral dermatitis.

Exactly.

And regarding lupus, the mellor butterfly rash is a flat or slightly raised erythema, but it lacks those pus -filled pustules.

Plus, a lupus patient will typically show systemic autoimmune activity, like testing positive for anti -nuclear antibodies, or ANA on a lab workup.

Spot on.

That differential is vital.

For managing rosacea, the primary intervention is lifestyle modification.

Identifying and avoiding triggers, intense sun, extreme heat, alcohol, spicy foods, things that cause vascular dilation.

Pharmacologically, topical metronidazole cream is the gold standard.

But here is a huge clinical trap to avoid.

Do not prescribe potent topical corticosteroids for facial redness.

Because it damages the skin barrier over time.

Yes.

And it causes steroid -induced rosacea.

The steroid temporarily blanches the redness by constricting blood vessels, but when they stop using it, the vessels dilate violently.

Giving them a severe rebound flare -up.

Exactly.

Don't do it.

Okay.

Let's pivot from inflammatory lesions to proliferative benign growths, the ones patients call the barnacles of aging.

Seborrheic keratosis.

Pathophysiologically, these are benign proliferations of immature keratinocytes.

They originate in the stratum corneum, the absolute outermost layer of the epidermis.

Visually, they are unmistakable.

Raised, waxy, scaly, hyperpigmented.

To me, it looks like someone took a piece of dark chewing gum or wax and just pressed it onto the skin.

Yeah.

It doesn't look like a tumor growing up from the deep dermal layers.

It has a very distinct stuck -on appearance.

And they're totally benign, right?

Zero risk of malignant transformation.

True.

However, they are tied to a profound systemic red flag.

The Lizard Trilocine.

The sudden explosive eruption of dozens or hundreds of seborrheic keratosis.

Usually accompanied by skin tags and acanthesis nigricans, which is that velvety hyperpigmentation in the skin folds.

Wait.

If the spots are benign, why is a sudden outbreak a medical emergency?

Because it's a perineoplastic syndrome.

An undetected internal malignancy, most commonly a gastrointestinal adenocarcinoma or a lung cancer is secreting massive amounts of growth factors into the bloodstream.

Oh, wow.

So those growth factors bind to receptors on the skin, forcing the epidermis to rapidly proliferate.

Exactly.

The skin lesions aren't cancerous, but they are a blaring alarm bell for a hidden tumor.

The skin acting as a mirror for the internal organs.

That is wild.

It really is.

Now looking at table 17 .1, we should briefly mention a few other benign growths you'll encounter.

Lopomas, which are benign, rubbery, compressible tumors made of subcutaneous fat.

And evils, which are your standard circumscribed moles.

And skin tags or acrochordans.

Those are soft, fleshy overgrowths on a stalk, usually caused by friction in areas like the armpits or neck.

And management for all of these is generally just observational.

Or cosmetic removal, using liquid nitrogen cryotherapy, electrosurgery, or a simple shave excision.

Right.

But, and this is the absolute golden rule for the APN, if the clinical diagnosis is ever uncertain and you cannot definitively rule out malignant melanoma, you do not freeze it.

You do not shave it off.

You refer the patient for a biopsy.

Never destroy evidence.

If you freeze a melanoma thinking it's a seborrheic keratosis, you delay a life -saving diagnosis and destroy the tissue the pathologist needs to stage the cancer.

Which brings us across the bridge from benign aging spots to lesions with a darker potential.

Let's examine actinic keratosis, or AK.

These are the most common pre -malignant skin lesions in primary care.

They are the direct, cumulative result of ultraviolet radiation.

UV rays penetrating the skin and damaging the DNA of the epithelial cells.

Specifically, they create thymine dimers.

These mutations prevent normal cellular replication.

Over decades, that cumulative DNA damage leads to the clonal expansion of mutated atypical cells.

You'll spot these on areas constantly battered by the sun.

The bald scalp, the tips of the ears, forearms, the face.

Visually, they appear as poorly circumscribed, slightly raised, scaly macules or plaques.

But your assessment cannot rely on inspection alone.

Right, palpation is mandatory.

When you run your finger over an AK, it feels rough, dry, and uneven.

Exactly like sandpaper.

That sandpaper texture is the clinical hallmark.

And because the damage is often widespread across a sun -exposed area, clinicians sometimes use fluorescents to aid diagnosis.

Oh, applying a photosensitizing drug and illuminating it with a woods lamp.

Yep.

The areas of mutated clonal expansion will glow bright pink, revealing the true extent of the invisible damage.

So why do we care so aggressively about a little rough patch?

Because a significant percentage of these lesions will undergo malignant transformation into squamous cell carcinoma.

Which is why interventions range from freezing isolated spots to prescribing topical chemotherapeutic agents like fluorosil to destroy the mutated cells.

But our priority health promotion strategy has to be relentless patient education on stopping further DNA damage.

Wide brimmed hats, UV protective clothing,

daily high SPF sunscreen.

Because the ultimate consequence of unmitigated UV damage brings us to the most dangerous lesion of all, malignant melanoma.

Melanoma is responsible for 75 % of all skin cancer deaths, even though it's far less common than other skin cancers.

It arises from the melanocytes, the pigment -producing cells, and the basal layer of the epidermis.

If caught during its radial growth phase when it's just spreading horizontally across the surface, it is highly curable.

But once it enters the vertical growth phase and invades the deeper dermis… Then its ability to reach the lymphatic system and metastasize is devastating.

You must assess all areas of the body.

Particularly checking the nail beds of older adults for subungual melanoma.

And the red flag physical finding there is Hutchinson's sign.

That's when the dark pigmentation of the melanoma leaks out from beneath the nail bed and discolors the posterior cuticle and the surrounding skin.

Exactly.

Now to assess general moles, we use the ABCDE mnemonic, asymmetry, border irregularity color variation, seeing chaotic mixtures of blue, black, brown, and red.

Diameter greater than 6 millimeters and evolving over time.

But I want to challenge that D for diameter.

I've heard students say, well, it's only 3 millimeters across, so it doesn't meet the criteria.

It's fine.

Is that a safe assumption?

That is a catastrophic assumption.

The ABCDE criteria are guidelines, not absolute rules.

Early, highly aggressive melanomas can absolutely present smaller than 6 millimeters.

So size isn't everything?

Not at all.

The most critical prognostic factor for a melanoma is not its surface diameter.

It is its Breslau thickness, meaning its exact microscopic depth of invasion into the dermis.

And if a melanoma penetrates deeper than 4 millimeters, the mortality rate skyrockets to 75%.

Yes.

And that biological fact circles right back to our golden rule about biopsies.

If depth is the ultimate decider of life or death, you can never perform a superficial shave biopsy on a suspected melanoma.

Because a shave biopsy slices off the top of the lesion and leaves the deep roots behind.

The pathologist receives a severed sample.

They cannot measure the true depth of invasion.

And without that depth, you cannot stage the cancer using the AJCC TNM system.

Which stands for tumor thickness, node involvement, and metastasis.

Suspected melanomas require an excisional biopsy, removing the entire lesion intact down to the subcutaneous fat, usually performed by a referred dermatologist or surgical oncologist.

We've covered the deadliest cancer.

Let's finish our diagnostic toolkit with the most common ones.

Non -melanominous skin cancers.

Specifically, basal cell carcinoma and squamous cell carcinoma.

Let's contrast them.

Basal cell carcinoma, or BCC,

arises from the basal cells at the very bottom of the epidermis.

It's slow -growing and locally invasive.

Meaning it aggressively destroys surrounding tissue but almost never metastasizes to other organs.

Clinically, it presents as a smooth, pearly, or translucent elevated papule.

If you look closely, you will often see tiny, branching, telangiectatic blood vessels crossing its surface.

And as it grows, the center frequently collapses into an ulceration.

Squamous cell carcinoma, or SEC, is an entirely different beast.

It originates from the keratinocides higher up in the epidermis.

Clinically presenting as a firm papule or plaque with a thick, scaly, keratotic surface.

A defining feature is that SEC lesions are highly friable.

They bleed very easily with minimal trauma, like just rubbing them with a towel.

And unlike BCC, squamous cell carcinoma absolutely possesses the lethal ability to metastasize.

The primary driver for both is cumulative UV exposure.

But there is a massive systemic risk factor that drastically alters the clinical picture.

Immunosuppression.

Because your immune system is constantly patrolling for cells expressing mutated tumor antigens.

Right.

But in patients taking chronic immunosuppressive medications like organ transplant recipients, preventing graft rejection that immunosurveillance is paralyzed.

The statistics on that are just staggering.

For a transplant patient, the risk of developing a BCC increases by a factor of 10.

But their risk of developing a squamous cell carcinoma is up to 250 times higher than the general population.

250 times?

That's unbelievable.

And those tumors emerge earlier, they grow faster, and they are far more aggressive.

You also must be aware that specific strains of the human papillomavirus, or HPV, are strongly linked to the development of antigenital SCC.

So skin cancer assessment definitely doesn't stop at the face and arms.

Management for both BCC and SCC generally involves surgical excision, which is highly curative if caught early.

And that highlights the critical role of the APN in primary care.

The U .S.

Preventive Services Task Force and the American Cancer Society strongly emphasize the need for regular skin self -examinations by patients.

Coupled with thorough, fully documented full -body skin exams by practitioners, especially for those high -risk populations.

Absolutely essential.

Well, we have traversed a massive amount of clinical territory today.

We analyzed the androgen -driven traffic jams of adolescent acne and distinguished them from the vascular flushing of adult rosacea.

We decoded the waxy barnacles of aging, palpated the sandpaper warnings of ectinic keratosis.

And finally, outlined the life -saving diagnostic logic needed to catch melanomas and carcinomas before they claim a life.

I think the overarching lesson here is to view the skin not as a static barrier, but as a profound dynamic mirror reflecting the internal state of the body.

I love that.

From the sudden eruption of the Leder -Tweylaw sign, revealing a hidden gastrointestinal tumor to a polarized immune system, unleashing a barrage of squamous cell carcinomas.

The skin is a highly active immunological landscape.

And it is always broadcasting information.

It's not wrapping paper.

It is your diagnostic canvas.

A sincere thank you to you for joining us, and a special shout out to the Last Minute Lecture team for bringing this together.

We wish you immense success in your clinical practice and on your upcoming exams.

Keep looking closely at that complex landscape.

It's always trying to tell you a story.